19 febrero 2025

GRÍFOLS Termina el Reclutamiento Para el Estudio Clínico de Alfa-1 15% en Pacientes con Alfa1_Antitripsina ( AAT ) .




Atezolizumab Induced Generalized Cutaneous Lichen Planus in a Patient With Metastatic Small Cell Lung Cancer Successfully Treated With Isotretinoin : A Case Report .



17 FEBRUARY 2025 .


Immune checkpoint inhibitors, now widely used in treating various malignancies, increase the risk of autoimmune reactions and immune-related adverse events (irAEs), with skin toxicities being the most frequent .

These agents enhance the immune response against tumors by blocking the suppression of cytotoxic T lymphocytes .


Here, we report a rare case of generalized cutaneous lichen planus induced by ATEZOLIZUMAB, an immune checkpoint inhibitor administered for SMALL CELL LUNG CÁNCER .

 After consulting with the oncologist, we opted to initiate isotretinoin as the first-line treatment .

 Considering the patient's oncologic status and multiple comorbidities, we aimed to avoid systemic corticosteroids due to their potential side effects .

This case was effectively managed with low-dose oral isotretinoin alongside high-potency topical corticosteroids. It emphasizes the need to consider retinoids as a potential treatment option for various dermatological conditions beyond acne .

 Isotretinoin may be beneficial in treating lichen planus by influencing cellular proliferation and promoting epithelial differentiation, though its exact mechanism remains uncertain .

 Additionally, it has notable anti-inflammatory effects and modulates immune responses. In such cases, isotretinoin may also enhance the therapeutic effects of topical corticosteroids through a synergistic interaction .



Trump : Sectorial Tariffs on PHARMACEUTICALS and SEMICONDUCTOR CHIPS Would Also Start at " 25% or Higher ", Rising Substantially Over The Course Of a Year .


Trump Says He Will Introduce 25% Tariffs on AUTOS , PHARMACEUTICALS And CHIPS .

REUTERS /// By Andrea Shalal and Nandita Bose // February 19, 2025 .


Pharma, Chip Firms May Face Tariffs Above 25%, Timing Uncertain . 

He Did Not Provide A Date For Announcing Those Duties And Said He Wanted To Provide Some Time For Drug And Chip Makers To Set Up U.S. Factories So That They Can Avoid Tariffs . ...